Literature DB >> 29664276

Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.

Lindsay P Cameron1, Charlie J Benson2, Lee E Dunlap2, David E Olson2,3,4.   

Abstract

Depression and anxiety disorders are debilitating diseases resulting in substantial economic costs to society. Traditional antidepressants often take weeks to months to positively affect mood and are ineffective for about 30% of the population. Alternatives, such as ketamine, a dissociative anesthetic capable of producing hallucinations, and the psychoactive tisane ayahuasca, have shown great promise due to their fast-acting nature and effectiveness in treatment-resistant populations. Here, we investigate the effects of N, N-dimethyltryptamine (DMT), the principle hallucinogenic component of ayahuasca, in rodent behavioral assays relevant to anxiety and depression using adult, male, Sprague-Dawley rats. We find that while DMT elicits initial anxiogenic responses in several of these paradigms, its long-lasting effects tend to reduce anxiety by facilitating the extinction of cued fear memory. Furthermore, DMT reduces immobility in the forced swim test, which is a characteristic behavioral response induced by many antidepressants. Our results demonstrate that DMT produces antidepressant and anxiolytic behavioral effects in rodents, warranting further investigation of ayahuasca and classical psychedelics as treatments for depression and post-traumatic stress disorder.

Entities:  

Keywords:  DMT; N,N-dimethyltryptamine; ayahuasca; depression; post-traumatic stress disorder; psychedelic

Mesh:

Substances:

Year:  2018        PMID: 29664276      PMCID: PMC7196340          DOI: 10.1021/acschemneuro.8b00134

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  74 in total

1.  Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.

Authors:  Aline Pic-Taylor; Luciana Gueiros da Motta; Juliana Alves de Morais; Willian Melo Junior; Alana de Fátima Andrade Santos; Leandro Ambrósio Campos; Marcia Renata Mortari; Marcus Vinicius von Zuben; Eloisa Dutra Caldas
Journal:  Behav Processes       Date:  2015-06-03       Impact factor: 1.777

2.  Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus.

Authors:  Jucélia J Fortunato; Gislaine Z Réus; Tamires R Kirsch; Roberto B Stringari; Gabriel R Fries; Flávio Kapczinski; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

3.  Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Authors:  Carlos A Zarate; Nancy E Brutsche; Lobna Ibrahim; Jose Franco-Chaves; Nancy Diazgranados; Anibal Cravchik; Jessica Selter; Craig A Marquardt; Victoria Liberty; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-01-31       Impact factor: 13.382

4.  Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.

Authors:  Jordi Riba; Marta Valle; Gloria Urbano; Mercedes Yritia; Adelaida Morte; Manel J Barbanoj
Journal:  J Pharmacol Exp Ther       Date:  2003-03-26       Impact factor: 4.030

Review 5.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

6.  In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat.

Authors:  B R Sitaram; L Lockett; R Talomsin; G L Blackman; W R McLeod
Journal:  Biochem Pharmacol       Date:  1987-05-01       Impact factor: 5.858

7.  Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus.

Authors:  Jucélia J Fortunato; Gislaine Z Réus; Tamires R Kirsch; Roberto B Stringari; Laura Stertz; Flávio Kapczinski; Joel P Pinto; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-07-24       Impact factor: 5.067

8.  Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.

Authors:  L M Adams; M A Geyer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1985       Impact factor: 5.067

Review 9.  Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Front Pharmacol       Date:  2013-12-27       Impact factor: 5.810

Review 10.  A simple practice guide for dose conversion between animals and human.

Authors:  Anroop B Nair; Shery Jacob
Journal:  J Basic Clin Pharm       Date:  2016-03
View more
  37 in total

1.  [Ayahuasca-induced psychosis in a patient with bipolar disorder].

Authors:  Nicolas Zellner; Tobias Zellner; Jan Warninghoff
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

Review 2.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

3.  Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse.

Authors:  Marcus W Meinhardt; Cansu Güngör; Ivan Skorodumov; Lea J Mertens; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2020-05-05       Impact factor: 7.853

4.  Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.

Authors:  Danilo De Gregorio; Argel Aguilar-Valles; Katrin H Preller; Boris Dov Heifets; Meghan Hibicke; Jennifer Mitchell; Gabriella Gobbi
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

5.  Psychedelic Microdosing: Prevalence and Subjective Effects.

Authors:  Lindsay P Cameron; Angela Nazarian; David E Olson
Journal:  J Psychoactive Drugs       Date:  2020-01-23

6.  Beneficial effects of vitamin D on anxiety and depression-like behaviors induced by unpredictable chronic mild stress by suppression of brain oxidative stress and neuroinflammation in rats.

Authors:  Hossein Bakhtiari-Dovvombaygi; Saeed Izadi; Mostafa Zare Moghaddam; Milad Hashemzehi; Mahmoud Hosseini; Hassan Azhdari-Zarmehri; Hossein Dinpanah; Farimah Beheshti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-27       Impact factor: 3.000

7.  Psychedelic-inspired drug discovery using an engineered biosensor.

Authors:  Chunyang Dong; Calvin Ly; Lee E Dunlap; Maxemiliano V Vargas; Junqing Sun; In-Wook Hwang; Arya Azinfar; Won Chan Oh; William C Wetsel; David E Olson; Lin Tian
Journal:  Cell       Date:  2021-04-28       Impact factor: 41.582

Review 8.  Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.

Authors:  Bashkim Kadriu; Maximillian Greenwald; Ioline D Henter; Jessica R Gilbert; Christoph Kraus; Lawrence T Park; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

Review 9.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162

10.  Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies.

Authors:  Lee E Dunlap; Arya Azinfar; Calvin Ly; Lindsay P Cameron; Jayashri Viswanathan; Robert J Tombari; Douglas Myers-Turnbull; Jack C Taylor; Ana Cristina Grodzki; Pamela J Lein; David Kokel; David E Olson
Journal:  J Med Chem       Date:  2020-01-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.